Clinical Trial Update: GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating the combination of a GnRH agonist with letrozole in obese women with progestin-insensitive endometrial atypical h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia

Drugs mentioned

• Letrozole (letrozole)
• Leuprolide (Leuprolide acetate)

Snippet

Sponsor: Xiaojun Chen | Conditions: Atypical Endometrial Hyperplasia, Progesterone Resistance | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING